Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. India API Industry Outlook
     3.1 Share of India in Global API Market
     3.2 Indian API Domestic Consumption Market Future Outlook
     3.3 Major APIs in the Indian API Market

4. Drivers & Challenges
     4.1 Drivers
            4.1.1 Rising Healthcare Expenditure
            4.1.2 Increasing Disposable Incomes
            4.1.3 Growing Geriatric Population
            4.1.4 Increasing Incidences of Chronic Diseases
            4.1.5 Patent Expiry of Blockbuster Drugs
            4.1.6 Increased Consumption of Generic Drugs
            4.1.7 Invention of New Generation of APIs
     4.2 Challenges
            4.2.1 Over dependence on China for Imports
            4.2.2 Complex License Renewal Procedure
            4.2.3 Few Manufacturers in the API Industry
            4.2.4 Inadequate Infrastructure Facilities
            4.2.5 Lack of Government Support
            4.2.6 Stringent Regulatory Policies

5. Market Segmentation
     5.1 By Type of Manufacturing
     5.2 By Type of API
     5.3 By Type of Therapeutic Area

6. Mergers and Acquisitions

7. Government Initiatives
     7.1 Katoch Committee
     7.2 'Make in India' Campaign
     7.3 Pharma Vision 2020
     7.4 Establishment of New NIPERs
     7.5 Set-Up of Reviewing Committee
     7.6 Launch of Fund by Government

8. Regulatory Scenario

9. Competitive Landscape
     9.1 Sun Pharma
     9.2 Cipla Limited
     9.3 Biocon
     9.4 Dr. Reddy's Laboratories
     9.5 Lupin Limited
     9.6 Aurobindo Pharma Limited
     9.7 Wockhardt
     9.8 Zydus Cadila
     9.9 Glenmark Pharmaceuticals
     9.10 Jubilant LifeSciences

10. Opportunities and Recommendations
       10.1 Opportunities
       10.2 Recommendations